“Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis”, Reumatismo, vol. 65, no. 2, pp. 75–78, May 2013, doi: 10.4081/reumatismo.2013.75.